Therapy of Ocular Behçet Disease
- 30 December 2013
- journal article
- review article
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 22 (1) , 64-76
Abstract
Ocular involvement in Behçet disease (BD) is characterized by recurrent inflammatory attacks and spontaneous resolution of acute inflammatory signs. Both frequency and severity of uveitis attacks determine the magnitude of irreversible damage to intraocular structures and long-term visual prognosis. Recurrent attacks of occlusive retinal vasculitis lead to vision-threatening complications such as cystoid macular edema, retinal neovascularization, optic atrophy and retinal atrophy. This manuscript updates about the role of various drugs in the management of BD, discussing corticosteroids, disease modifying immunosuppressive drugs, and finally biologicals (anti-TNF-blocking agents and alpha interferon) which seem to be superior compared to all other available drugs in preventing loss of vision. Also recent findings from new biologicals will be summarized, and especially the role of these drugs in children will be discussed in detail. The authors suggest that at least moderate to severe retinal involvement should become treated with biologicals whenever available.Keywords
This publication has 125 references indexed in Scilit:
- Secukinumab in the Treatment of Noninfectious Uveitis: Results of Three Randomized, Controlled Clinical TrialsOphthalmology, 2013
- Behçet Disease: Visual Prognosis and Factors Influencing the Development of Visual LossAmerican Journal of Ophthalmology, 2011
- Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's diseaseNature Genetics, 2010
- Mycophenolate Mofetil for the Treatment of UveitisAmerican Journal of Ophthalmology, 2008
- Ocular features of Behcet's disease: An international collaborative studyBritish Journal of Ophthalmology, 2007
- Biological response modifier therapy for refractory childhood uveitisBritish Journal of Ophthalmology, 2007
- Successful treatment of refractory neuro-Behçet's disease with infliximab: a case report to show its efficacy by magnetic resonance imaging, transcranial magnetic stimulation and cytokine profileAnnals of the Rheumatic Diseases, 2007
- A Double-masked, Randomized Study to Investigate the Safety and Efficacy of Daclizumab to Treat the Ocular Complications Related to Behçet's DiseaseOcular Immunology and Inflammation, 2007
- Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patientsBritish Journal of Ophthalmology, 2006
- A Controlled Trial of Azathioprine in Behçet's SyndromeNew England Journal of Medicine, 1990